Non-Sponsored Content

Non-Sponsored

Non-Sponsored

Advertisement

Study Investigates Targeted Interventions to Improve Lung Cancer Screening Uptake in High-Risk Patients

Laura LitwinNon-Sponsored | July 2, 2025

The study examined the effectiveness of various interventions aimed at increasing lung cancer screening uptake rates.

Should Immunotherapy Be Administered Earlier in the Day? Thoracic Oncologist Weighs in on New ASCO 2025 Data

Jorge Nieva, MDASCO 2025 | June 30, 2025

Jorge Nieva, MD, discusses a recent study that evaluated the impact of circadian rhythms on the efficacy of immunotherapy.

Countering Immune Evasion in SCLC: Triparna Sen, PhD, Shares Insights on Drivers of MHC Repression

Triparna Sen, PhDASCO 2025 | June 24, 2025

Dr. Sen explains how her team identified targetable genes that define immune suppression in small cell lung cancer.

How a Team Implemented Outpatient Administration of Tarlatamab for SCLC

Jennifer W. Carlisle, MDASCO 2025 | June 24, 2025

Jennifer Carlisle, MD, shares her institution’s experience with outpatient administration of the bispecific T-cell ...

Lung Cancer Risk: The Role of Family History and Germline Genetic Alterations

Cheryl Czerlanis, MDASCO 2025 | June 24, 2025

Cheryl Czerlanis, MD, shares insights from her ASCO 2025 presentation on the topic.

Advertisement

Advertisement

Latest News

Study Investigates Targeted Interventions to Improve Lung Cancer Screening Uptake in High-Risk Patients

July 2, 2025

HERTHENA-Lung02 Evaluates Patritumab Deruxtecan in EGFR-Mutated NSCLC

July 2, 2025

DART Trial Assesses Relationship Between ctDNA and Outcomes in Unresectable NSCLC

July 1, 2025

ASCO 2025: Dr. Alexi Archambault Discusses the First-Line Combination of Cemiplimab and Chemotherapy for NSCLC

June 30, 2025

ASCO 2025: Dr. Paul Conkling Shares Insights on PD-L1 Testing Practices in Metastatic NSCLC

June 27, 2025

The Oncology Forum: Expert Panel Weighs in On Advancements in the Lung Cancer Landscape

June 27, 2025